多巴胺转运体介导抗精神病药疗效、失效及逆转的机制
该研究在大鼠模型中探讨抗精神病药疗效随时间下降的机制,发现疗效与纹状体细胞外多巴胺水平同步下降,而非D2受体占据不足。疗效与多巴胺转运体活性抑制相关,失效时该抑制被逆转,且伴随多巴胺神经元放电减少和突触场反应增强。药理学抑制多巴胺转运体可挽救治疗结局,提示其可能是抗精神病药主要靶点及逆转失效的辅助策略。
要点
- 抗精神病药疗效下降与纹状体细胞外多巴胺水平降低同步,而非D2受体占据不足。
- 疗效期多巴胺转运体活性被抑制,失效时该抑制被逆转,且多巴胺神经元放电减少。
- 药理学抑制多巴胺转运体可挽救抗精神病药治疗结局,提示其作为辅助治疗靶点。
核心结论
- 抗精神病药疗效下降与大鼠纹状体细胞外多巴胺水平降低同步,而非D2受体占据不足。
- 多巴胺转运体活性抑制与疗效相关,失效时该抑制被逆转,药理学抑制多巴胺转运体可挽救治疗结局。
研究设计与样本
- 研究在大鼠模型中开展,观察抗精神病药疗效变化与多巴胺系统指标的关系。
主要发现
- 抗精神病药疗效下降与纹状体细胞外多巴胺水平降低同步,而非D2受体占据不足。
- 疗效与多巴胺转运体活性抑制相关,失效时该抑制被逆转。
- 失效时多巴胺神经元放电减少,而疗效期未观察到此现象。
- 突触场反应在疗效期下降,失效期增强;抗精神病药在疗效期阻断突触囊泡释放,失效期增强释放。
- 药理学抑制多巴胺转运体可挽救抗精神病药治疗结局。
临床怎么用
- 多巴胺转运体阻断剂可能作为辅助治疗逆转抗精神病药治疗失效。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Antipsychotic drugs are effective interventions in schizophrenia. However, the efficacy of these agents often decreases over time, which leads to treatment failure and symptom recurrence. We report that antipsychotic efficacy in rat models declines in concert with extracellular striatal dopamine levels rather than insufficient dopamine D2 receptor occupancy. Antipsychotic efficacy was associated with a suppression of dopamine transporter activity, which was reversed during failure. Antipsychotic failure coincided with reduced dopamine neuron firing, which was not observed during antipsychotic efficacy. Synaptic field responses in dopamine target areas declined during antipsychotic efficacy and showed potentiation during failure. Antipsychotics blocked synaptic vesicle release during efficacy but enhanced this release during failure. We found that the pharmacological inhibition of the dopamine transporter rescued antipsychotic drug treatment outcomes, supporting the hypothesis that the dopamine transporter is a main target of antipsychotic drugs and predicting that dopamine transporter blockers may be an adjunct treatment to reverse antipsychotic treatment failure.
引用
- Amato D, Canneva F, Cumming P, et al. A dopaminergic mechanism of antipsychotic drug efficacy, failure, and failure reversal: the role of the dopamine transporter. Mol Psychiatry. 2018. PMID: 30038229. doi:10.1038/s41380-018-0114-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。